Rad AI Named to the 2025 CB Insights’ List of the 50 Most Promising Digital Health Startups

NEW YORK, October 20, 2025 – CB Insights today named Rad AI to its seventh annual Digital Health 50, showcasing the 50 most promising private digital health companies in the world.

“The 2025 Digital Health 50 winners are high-momentum companies poised to define the next era of healthcare,” said Ellen Knapp, Principal Analyst at CB Insights. “This year’s cohort is advancing the shift from reactive to proactive care, developing AI solutions tailored to healthcare's unique regulatory environment, and addressing critical sector-wide challenges from care access to provider burnout and workforce shortages.”

“At Rad AI, our mission has always been simple — to empower physicians with AI that saves time, reduces burnout, and improves patient care,” said Doktor Gurson, Co-founder and CEO of Rad AI. “Being recognized by CB Insights for Workflow Automation in Diagnostics & Imaging underscores the real-world impact of our physician-led approach. We’re proud to help radiology teams work smarter, not harder, and to continue shaping the future of healthcare with AI built by radiologists, for radiologists.”

The list primarily includes early- and mid-stage startups driving innovation across digital health. Our research team picked winning companies based on CB Insights datasets, including deal activity, industry partnerships, team strength, investor strength, employee headcount, and proprietary Commercial Maturity and Mosaic scores. We also dug into Analyst Briefings submitted directly to us by startups.

Rad AI is the leader in generative AI solutions for radiology, transforming the way radiologists work and improving patient care. The company's flagship product, Rad AI Reporting, streamlines radiology reporting with AI-driven technology and empowers radiologists to achieve greater efficiency, accuracy, and satisfaction. Rad AI Impressions, the company's pioneering product, established Rad AI as an innovator in generative AI for radiology; as the first generative AI application to achieve widespread adoption in radiology, it is now trusted by thousands of US radiologists. Rad AI Continuity, the most comprehensive solution of its kind, uses AI to help ensure patient follow-up for potential new cancers.

The company has been recognized as one of the most promising healthcare AI companies by CB Insights (Digital Health 50, AI 100) and AuntMinnie (Best New Radiology Software 2023, Best New Radiology Vendor 2021). In November of 2024, Rad AI was named the 19th fastest-growing company in North America on the Deloitte Fast 500. In 2025, the company was selected as one of CNBC's Disruptor 50, which highlighted the most innovative companies in generative AI.

Learn more about Rad AI at www.radai.com or on LinkedIn at www.linkedin.com/company/radai/. 

Quick facts on the 2025 Digital Health 50:

• The 50 winners span categories such as care delivery, revenue cycle management, drug discovery & development, and diagnostics.
• This year's cohort is deploying AI across a wide variety of use cases, with notable adoption of agentic AI, voice AI, and automated provider workflows.
• Collectively raised $2B in equity funding in 2025 YTD (as of 10/14/2025).
• 52% are early-stage companies (seed/angel or Series A funding).
• Established 140+ business relationships since 2024 with industry leaders including Cleveland Clinic, IBM, and Novartis.

About CB Insights

CB Insights is the leader in predictive intelligence on private companies. It delivers instant insights that help you source and analyze private companies, focus on the right markets, and stay ahead of competitors. Our AI agents are powerful because they translate signals into the exact outputs your teams need to move first — defensible, sourced, and board-ready. To learn more, please visit www.cbinsights.com. 

Contact:

Media@cbinsights.com